Pharmaceutical Technology-08-01-2014

August 01, 2014

Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.

August 01, 2014

Contract service providers describe how quality by design has influenced a drug sponsor's expectations of suppliers.

August 01, 2014

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.

August 01, 2014

Representatives of contract service organizations that develop biologic-based drugs discussed technology trends such as high-throughput screening and single-use systems.

August 01, 2014

Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.

August 01, 2014

Contract services ride high as funding floods bio/pharma.

August 01, 2014

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

August 01, 2014

Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.

August 01, 2014

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

August 01, 2014

For a bio/pharma industry in flux, contract services are playing a greater-and more diverse-role in drug development.

August 01, 2014

Pharmaceutical Technology Europe Marks 25 years of drug-development advances.

August 01, 2014

Control charts that are properly constructed and maintained prevent false out-of-control signals and provide a useful method for monitoring a process.